Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Cash from Operations (2016 - 2026)

Rockwell Medical filings provide 16 years of Cash from Operations readings, the most recent being 2341000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 170.64% to 2341000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 659000.0, a 115.68% decrease, with the full-year FY2025 number at 659000.0, down 115.68% from a year prior.
  • Cash from Operations hit 2341000.0 in Q4 2025 for Rockwell Medical, up from 1357000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 4275000.0 in Q3 2024 to a low of 12495000.0 in Q1 2021.
  • Median Cash from Operations over the past 5 years was 2060000.0 (2023), compared with a mean of 2816600.0.
  • Biggest five-year swings in Cash from Operations: tumbled 240.56% in 2023 and later surged 2111.63% in 2024.
  • Rockwell Medical's Cash from Operations stood at 9026000.0 in 2021, then soared by 98.76% to 112000.0 in 2022, then soared by 61.61% to 43000.0 in 2023, then surged by 2111.63% to 865000.0 in 2024, then surged by 170.64% to 2341000.0 in 2025.
  • The last three reported values for Cash from Operations were 2341000.0 (Q4 2025), 1357000.0 (Q3 2025), and 1844000.0 (Q2 2025) per Business Quant data.